A recent paper in the New England Journal of Medicine once again highlights the fact that we tend to ignore certain older disease states that we have archived before their demise. TB is one of these. In developed countries it rarely gets a mention, except in immune-compromised patients. In Third World countries TB is still an issue.
The World Health Organisation (WHO) in 2014 places mortality at 1.5 million, with a total of 9.6 million infected individuals(http://www.who.int/mediacentre/factsheets/fs104/en/).
The study carried out in the article emphasises that intensified therapy does not improve intervention outcomes and that mortality is still significant. In a global context, more emphasis must be placed on eradicating basic and long-standing communicable disease, prior to simply discovering new ways in which to market and monetise pharmaceutical care!
The paper, "Intensified Antituberculosis Therapy in Adults with Tuberculous Meningitis",
can be found @http://www.nejm.org/doi/full/10.1056/NEJMoa1507062.
The World Health Organisation (WHO) in 2014 places mortality at 1.5 million, with a total of 9.6 million infected individuals(http://www.who.int/mediacentre/factsheets/fs104/en/).
The study carried out in the article emphasises that intensified therapy does not improve intervention outcomes and that mortality is still significant. In a global context, more emphasis must be placed on eradicating basic and long-standing communicable disease, prior to simply discovering new ways in which to market and monetise pharmaceutical care!
The paper, "Intensified Antituberculosis Therapy in Adults with Tuberculous Meningitis",
can be found @http://www.nejm.org/doi/full/10.1056/NEJMoa1507062.
